NCT00264576View on ClinicalTrials.gov

Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

613

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

May 31, 2006

Conditions
Influenza Disease; Flu
Interventions
BIOLOGICAL

Influenza Virus Vaccine

Trial Locations (4)

15241

Pittsburgh

40004

Bardstown

84109

Salt Lake City

84121

Salt Lake City

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
collaborator

Novartis Vaccines and Diagnostics (formerly Chiron Vaccines)

UNKNOWN

lead

Novartis Vaccines

INDUSTRY

NCT00264576 - Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults | Biotech Hunter | Biotech Hunter